Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03746080 |
|
Recruitment Status :
Recruiting
First Posted : November 19, 2018
Last Update Posted : July 11, 2022
|
Sponsor:
Lawrence D Recht
Collaborator:
Sanofi
Information provided by (Responsible Party):
Lawrence D Recht, Stanford University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2023 |
| Estimated Study Completion Date : | July 2027 |